Additionally, the identification of NOTCH1 aberrations in hematopoietic stem cells of CLL patients highlighted the contribution of NOTCH1 in driving the clonal expansion of cancer cells [38], suggesting that NOTCH1 inhibition could potentially lead to CLL regression or contrasting RT progression. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.